AustraZeneca | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
May 19, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, MAY 19, 2025

AustraZeneca

A bottle of Pfizer/BioNTech vaccine against the coronavirus disease (Covid-19) is pictured as the first batch is being defrosted at the Gasthuisberg hospital in Leuven, Belgium December 27, 2020. Fred Sierakowski/Pool via REUTERS
Coronavirus chronicle

Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen

It is expected more vaccines will be added to the trial when they are approved and rolled out

A test tube labeled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. Photo: REUTERS/Dado Ruvic
Coronavirus chronicle

New Austrazeneca/Oxford vaccine ready to tackle coronavirus variant 

A woman holds a small bottle labeled with a "Vaccine Covid-19" sticker and a medical syringe in this illustration taken April 10, 2020/Reuters
Coronavirus chronicle

Chinese vaccine producer claims their shots to be safe amid Oxford's setback

FILE PHOTO: The World Health Organization (WHO) logo is pictured at the entrance of its headquarters in Geneva, January 25, 2015. REUTERS/Pierre Albouy/File Photo
Coronavirus chronicle

WHO says vaccine safety top priority, as AstraZeneca pauses study

Pause in AstraZeneca vaccine trial not necessarily a setback, says UK health minister
Coronavirus chronicle

Pause in AstraZeneca vaccine trial not necessarily a setback, says UK health minister

The urgent need for effective Covid-19 treatments and vaccines is causing a shift in drugmakers’ priorities. Photographer:  Andrey Rudakov/Bloomberg
Coronavirus chronicle

'Looking forward to the Covid-19 vaccine,' said CEO of Indian Serum Institute 

Scientists around the world are racing to develop a vaccine. Photo: Xinhua
Coronavirus chronicle

Australia hopeful to roll out nearly 85 million vaccine doses, says PM Morrison

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net